• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制组蛋白脱乙酰酶活性可减轻梗阻性肾病中肾成纤维细胞的活化和间质纤维化。

Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.

作者信息

Pang Maoyin, Kothapally Jagan, Mao Haiping, Tolbert Evelyn, Ponnusamy Murugavel, Chin Y Eugene, Zhuang Shougang

机构信息

Department of Medicine, Brown Univ. School of Medicine, Rhode Island Hospital, Providence, RI 02903, USA.

出版信息

Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005. doi: 10.1152/ajprenal.00282.2009. Epub 2009 Jul 29.

DOI:10.1152/ajprenal.00282.2009
PMID:19640900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2775583/
Abstract

Activation of renal interstitial fibroblasts is critically involved in the development of tubulointerstitial fibrosis in chronic kidney diseases. In this study, we investigated the effect of trichostatin A (TSA), a specific histone deacetylase (HDAC) inhibitor, on the activation of renal interstitial fibroblasts in a rat renal interstitial fibroblast line (NRK-49F) and the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO). alpha-Smooth muscle actin (alpha-SMA) and fibronectin, two hallmarks of fibroblast activation, were highly expressed in cultured NRK-49F cells, and their expression was inhibited in the presence of TSA. Similarly, administration of TSA suppressed the expression of alpha-SMA and fibronectin and attenuated the accumulation of renal interstitial fibroblasts in the kidney after the obstructive injury. Activation of renal interstitial fibroblasts was accompanied by phosphorylation of signal transducer and activator of transcription 3 (STAT3), and TSA treatment also abolished these responses. Furthermore, inhibition of the STAT3 pathway with AG490 inhibited expression of alpha-SMA and fibronectin in NRK-49F cells. Finally, TSA treatment inhibited tubular cell apoptosis and caspase-3 activation in the obstructive kidney. Collectively, we suggest that pharmacological HDAC inhibition may induce antifibrotic activity by inactivation of renal interstitial fibroblasts and inhibition of renal tubular cell death. STAT3 may mediate those actions of HDACs.

摘要

肾间质成纤维细胞的激活在慢性肾脏病肾小管间质纤维化的发展过程中起关键作用。在本研究中,我们调查了曲古抑菌素A(TSA)(一种特异性组蛋白脱乙酰酶(HDAC)抑制剂)对大鼠肾间质成纤维细胞系(NRK-49F)中肾间质成纤维细胞激活的影响以及对单侧输尿管梗阻(UUO)小鼠模型肾纤维化发展的影响。α-平滑肌肌动蛋白(α-SMA)和纤连蛋白是成纤维细胞激活的两个标志,在培养的NRK-49F细胞中高表达,且在TSA存在的情况下其表达受到抑制。同样,给予TSA可抑制α-SMA和纤连蛋白的表达,并减轻梗阻性损伤后肾脏中肾间质成纤维细胞的积聚。肾间质成纤维细胞的激活伴随着信号转导和转录激活因子3(STAT3)的磷酸化,TSA处理也消除了这些反应。此外,用AG490抑制STAT3途径可抑制NRK-49F细胞中α-SMA和纤连蛋白的表达。最后,TSA处理可抑制梗阻性肾脏中肾小管细胞凋亡和半胱天冬酶-3的激活。总体而言,我们认为药理学上抑制HDAC可能通过使肾间质成纤维细胞失活和抑制肾小管细胞死亡来诱导抗纤维化活性。STAT3可能介导HDAC的这些作用。

相似文献

1
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.抑制组蛋白脱乙酰酶活性可减轻梗阻性肾病中肾成纤维细胞的活化和间质纤维化。
Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005. doi: 10.1152/ajprenal.00282.2009. Epub 2009 Jul 29.
2
Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.阻断 I 类组蛋白去乙酰化酶可通过调节 TGF-β和 EGFR 信号通路改善肾纤维化并抑制肾成纤维细胞活化。
PLoS One. 2013;8(1):e54001. doi: 10.1371/journal.pone.0054001. Epub 2013 Jan 16.
3
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.新型 STAT3 抑制剂 S3I-201 可减轻梗阻性肾病肾间质成纤维细胞的激活和间质纤维化。
Kidney Int. 2010 Aug;78(3):257-68. doi: 10.1038/ki.2010.154. Epub 2010 Jun 2.
4
Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.阻断 SIRT1 和 SIRT2 可抑制肾间质成纤维细胞的激活,减轻梗阻性肾病所致的肾间质纤维化。
J Pharmacol Exp Ther. 2014 Aug;350(2):243-56. doi: 10.1124/jpet.113.212076. Epub 2014 May 15.
5
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.紫杉醇通过抑制信号转导和转录激活因子3(STAT3)信号通路减轻肾间质成纤维细胞活化和间质纤维化。
Drug Des Devel Ther. 2015 Apr 15;9:2139-48. doi: 10.2147/DDDT.S81390. eCollection 2015.
6
Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.鉴定组蛋白去乙酰化酶 8 为肾纤维化的一个新型治疗靶点。
FASEB J. 2020 Jun;34(6):7295-7310. doi: 10.1096/fj.201903254R. Epub 2020 Apr 12.
7
Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins.组蛋白去乙酰化酶 1/2 介导肾间质成纤维细胞的增殖和细胞周期蛋白的表达。
J Cell Biochem. 2011 Aug;112(8):2138-48. doi: 10.1002/jcb.23135.
8
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.Src 抑制可阻断肾间质成纤维细胞活化并改善肾纤维化。
Kidney Int. 2016 Jan;89(1):68-81. doi: 10.1038/ki.2015.293. Epub 2016 Jan 4.
9
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.选择性抑制 IIa 类组蛋白去乙酰化酶可减轻肾纤维化。
FASEB J. 2019 Jul;33(7):8249-8262. doi: 10.1096/fj.201801067RR. Epub 2019 Apr 5.
10
Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway.参康通过 JAK2/STAT3 通路对肾纤维化及肾间质成纤维细胞激活的影响。
BMC Complement Med Ther. 2021 Jan 6;21(1):12. doi: 10.1186/s12906-020-03180-3.

引用本文的文献

1
Bone morphogenetic proteins (BMPs) at the forefront of ocular diseases and therapeutics.骨形态发生蛋白(BMPs)在眼部疾病与治疗领域处于前沿地位。
Eye Vis (Lond). 2025 Jul 23;12(1):29. doi: 10.1186/s40662-025-00445-1.
2
HDAC11 promotes renal fibrosis by induing partial epithelial-mesenchymal transition and G2/M phase arrest in renal epithelial cells.组蛋白去乙酰化酶11通过诱导肾上皮细胞发生部分上皮-间质转化和G2/M期阻滞来促进肾纤维化。
Res Sq. 2025 May 6:rs.3.rs-6523050. doi: 10.21203/rs.3.rs-6523050/v1.
3
Role of histone deacetylase inhibitors in non-neoplastic diseases.组蛋白去乙酰化酶抑制剂在非肿瘤性疾病中的作用。
Heliyon. 2024 Jul 2;10(13):e33997. doi: 10.1016/j.heliyon.2024.e33997. eCollection 2024 Jul 15.
4
Tenovin-1, a Selective SIRT1/2 Inhibitor, Attenuates High-fat Diet-induced Hepatic Fibrosis via Inhibition of HSC Activation in ZDF Rats.Tenovin-1,一种选择性 SIRT1/2 抑制剂,通过抑制 ZDF 大鼠 HSC 的活化来减轻高脂肪饮食诱导的肝纤维化。
Int J Biol Sci. 2024 Jun 11;20(9):3334-3352. doi: 10.7150/ijbs.97304. eCollection 2024.
5
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis.成纤维细胞和肌成纤维细胞在正常组织修复和纤维化中的激活。
Nat Rev Mol Cell Biol. 2024 Aug;25(8):617-638. doi: 10.1038/s41580-024-00716-0. Epub 2024 Apr 8.
6
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis.组蛋白去乙酰化酶 3 在调控肾脏炎症和纤维化中的关键作用。
Kidney Int. 2024 Apr;105(4):775-790. doi: 10.1016/j.kint.2024.01.010. Epub 2024 Jan 28.
7
Valproic acid treatment attenuates cisplatin-induced kidney injury by suppressing proximal tubular cell damage.丙戊酸通过抑制近端肾小管细胞损伤来减轻顺铂诱导的肾损伤。
Clin Transl Sci. 2023 Nov;16(11):2369-2381. doi: 10.1111/cts.13638. Epub 2023 Sep 25.
8
Sex-specific epigenetic programming in renal fibrosis and inflammation.性别特异性的肾纤维化和炎症中的表观遗传编程。
Am J Physiol Renal Physiol. 2023 Nov 1;325(5):F578-F594. doi: 10.1152/ajprenal.00091.2023. Epub 2023 Aug 10.
9
Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.增强子结合锌指蛋白 2 通过诱导上皮-间充质转化和激活 M2 巨噬细胞极化促进急性肾损伤后的肾纤维化。
Cell Death Dis. 2023 Apr 7;14(4):253. doi: 10.1038/s41419-023-05782-4.
10
Kidney fibrosis: from mechanisms to therapeutic medicines.肾脏纤维化:从机制到治疗药物。
Signal Transduct Target Ther. 2023 Mar 17;8(1):129. doi: 10.1038/s41392-023-01379-7.

本文引用的文献

1
A phosphorylation-acetylation switch regulates STAT1 signaling.磷酸化-乙酰化开关调节信号转导和转录激活因子1(STAT1)信号传导。
Genes Dev. 2009 Jan 15;23(2):223-35. doi: 10.1101/gad.479209.
2
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin.组蛋白去乙酰化酶抑制作用可逆转心脏肥大中与血管紧张素无关的房性心律失常易感性和纤维化。
J Mol Cell Cardiol. 2008 Dec;45(6):715-23. doi: 10.1016/j.yjmcc.2008.08.015. Epub 2008 Sep 16.
3
Histone deacetylase inhibitors in cancer therapy.组蛋白去乙酰化酶抑制剂在癌症治疗中的应用
Curr Opin Oncol. 2008 Nov;20(6):639-49. doi: 10.1097/CCO.0b013e3283127095.
4
Lysine acetylation: codified crosstalk with other posttranslational modifications.赖氨酸乙酰化:与其他翻译后修饰的编码串扰。
Mol Cell. 2008 Aug 22;31(4):449-461. doi: 10.1016/j.molcel.2008.07.002.
5
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.使用阿皮西丁衍生物抑制I类组蛋白去乙酰化酶可预防心脏肥大和衰竭。
Cardiovasc Res. 2008 Dec 1;80(3):416-24. doi: 10.1093/cvr/cvn215. Epub 2008 Aug 12.
6
Histone deacetylase inhibitors in cancer therapy: new compounds and clinical update of benzamide-type agents.组蛋白去乙酰化酶抑制剂在癌症治疗中的应用:新型化合物及苯甲酰胺类药物的临床进展
Curr Top Med Chem. 2008;8(10):841-58. doi: 10.2174/156802608784911581.
7
Isoform-selective histone deacetylase inhibitors.亚型选择性组蛋白脱乙酰酶抑制剂
Chem Soc Rev. 2008 Jul;37(7):1402-13. doi: 10.1039/b703830p. Epub 2008 May 8.
8
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.伏立诺他抑制STAT6介导的TH2细胞因子和TARC的产生,并诱导霍奇金淋巴瘤细胞系发生细胞死亡。
Blood. 2008 Aug 15;112(4):1424-33. doi: 10.1182/blood-2008-01-133769. Epub 2008 Jun 9.
9
Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents.组蛋白去乙酰化酶抑制剂(一类抗癌药物)诱导肾小管细胞凋亡
J Pharmacol Exp Ther. 2008 Jun;325(3):978-84. doi: 10.1124/jpet.108.137398. Epub 2008 Feb 29.
10
Tubulin modifications and their cellular functions.微管蛋白修饰及其细胞功能。
Curr Opin Cell Biol. 2008 Feb;20(1):71-6. doi: 10.1016/j.ceb.2007.11.010. Epub 2008 Jan 15.